Several other research firms have also issued reports on HRC. Zacks Investment Research lowered shares of Hill-Rom from a “hold” rating to a “sell” rating in a research note on Friday, March 1st. Barclays increased their target price on shares of Hill-Rom from $103.00 to $108.00 and gave the stock an “equal weight” rating in a research note on Monday, April 15th. Finally, Needham & Company LLC reissued a “buy” rating and set a $116.00 target price on shares of Hill-Rom in a research note on Monday, March 11th. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $108.00.
Shares of HRC opened at $103.90 on Tuesday. The stock has a market cap of $6.90 billion, a price-to-earnings ratio of 21.87, a P/E/G ratio of 1.78 and a beta of 0.90. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.27 and a current ratio of 1.69. Hill-Rom has a fifty-two week low of $81.82 and a fifty-two week high of $108.68.
Several hedge funds have recently bought and sold shares of HRC. Oregon Public Employees Retirement Fund boosted its stake in shares of Hill-Rom by 8,755.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 2,281,991 shares in the last quarter. Hanseatic Management Services Inc. purchased a new stake in shares of Hill-Rom during the 1st quarter worth about $30,000. Sageworth Trust Co purchased a new stake in shares of Hill-Rom during the 1st quarter worth about $32,000. Financial Gravity Companies Inc. purchased a new position in Hill-Rom in the 4th quarter valued at about $48,000. Finally, Financial Gravity Wealth Inc. purchased a new position in Hill-Rom in the 1st quarter valued at about $53,000. 81.31% of the stock is currently owned by institutional investors and hedge funds.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Recommended Story: What is a back-end load?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.